Nonprofit · EIN 62-1250943
THE THOMPSON CANCER SURVIVAL CENTER
Tax-exempt · KNOXVILLE, TN 37932
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $7,887,756 | $13,462,262 | -$5,574,506 | $57,041,728 | $1,905,805 | $55,135,923 |
| December 31, 2023 | 990 | $8,057,852 | $12,677,535 | -$4,619,683 | $58,441,095 | $1,860,073 | $56,581,022 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $2,897,608
- Program service revenue
- $4,990,148
- Investment income
- $0
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $126,067
- Compensation of officers, directors and key employees
- $452,329
- Other salaries and wages
- $3,802,553
- Salaries, compensation and benefits (total)
- $5,660,294
- Professional fundraising fees
- $0
- Occupancy
- $1,485,706
- Travel
- $11,875
- Depreciation
- $2,242,409
- Program services (functional)
- $11,975,987
- Management and general (functional)
- $1,486,275
Balance sheet and other
- Total assets, start of year
- $58,441,095
- Total assets, end of year
- $57,041,728
- Total liabilities, end of year
- $1,905,805
- Net assets, end of year
- $55,135,923
- Land, buildings and equipment
- $56,203,494
- Net assets without donor restrictions
- $55,135,923
- Gross unrelated business income
- $703,001
- Gross receipts
- $7,887,756
- Employees
- 76
- Volunteers
- 25
- Year formed
- 1985
- State of legal domicile
- TN
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| James D VanderSteeg | President & CEO Trustee or director, Officer | 0 | $0 | $2,880,556 | $362,274 |
| Joseph C Dolan | EVP/CFO Officer | 0 | $0 | $861,693 | $105,608 |
| Benjamin J Devore | President & CAO Officer | 30 | $23,459 | $245,069 | $40,293 |
| Chester R Ramsey | Chief Medical Physicist Highest-paid employee | 5 | $254,276 | $0 | $46,586 |
| Jessica N Hodge | VP - Medical Oncology Key employee | 50 | $177,258 | $0 | $44,589 |
| Mitzi F Anderson | VP - Financial Services Officer | 7 | $170,366 | $0 | $28,824 |
| Jennifer A Turner | VP Radiation Oncology/CSO Highest-paid employee | 50 | $142,258 | $0 | $38,372 |
| Nicholeah J Lewallen | Pharmacy Manager Highest-paid employee | 50 | $135,606 | $0 | $39,855 |
| Carol S Mickey | Director of Radiation Oncology Highest-paid employee | 50 | $132,287 | $0 | $40,091 |
| Jennifer F Maulick | Director Patient Quality and Safety Highest-paid employee | 50 | $110,793 | $0 | $28,363 |
| Leslye Hartsell | Director Trustee or director | 0 | $0 | $1,124 | $0 |
| Cosby Stone | Director Trustee or director | 0 | $0 | $1,113 | $0 |
| James Tramontana MD | Director Trustee or director | 0 | $0 | $1,086 | $0 |
| William Seale | Director Trustee or director | 0 | $0 | $1,060 | $0 |
| Stephanie Flood | Director Trustee or director | 0 | $0 | $964 | $0 |
14 more people on this return
| Name | Title | Hours / week | Compensation | From related orgs |
|---|---|---|---|---|
| King Purnell | Director/Chair Trustee or director, Officer | 0 | $0 | $935 |
| Joe Sutter | Director Trustee or director | 0 | $0 | $881 |
| Edgar Gray | Director Trustee or director | 0 | $0 | $844 |
| Jorge Sanabria | Director Trustee or director | 0 | $0 | $807 |
| Donald Hickman | Director Trustee or director | 0 | $0 | $675 |
| Timothy Matthews | Director Trustee or director | 0 | $0 | $657 |
| Alvin Nance | Director Trustee or director | 0 | $0 | $648 |
| Mitchell Dickson MD | Director Trustee or director | 0 | $0 | $0 |
| James Gibson | Director Trustee or director | 0 | $0 | $0 |
| Janice McKinley | Director Trustee or director | 0 | $0 | $0 |
| Cletus McMahon MD | Director Trustee or director | 0 | $0 | $0 |
| Dave Miller | Director Trustee or director | 0 | $0 | $0 |
| Bill Myers | Director Trustee or director | 0 | $0 | $0 |
| Linda Ogle | Director Trustee or director | 0 | $0 | $0 |
990 for the year ended December 31, 2023: 34 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| James D VanderSteeg | President & CEO Trustee or director, Officer | 0 | $0 | $2,762,691 | $352,568 |
| John T Geppi | Fmr EVP/CFO (through June 2023) Officer | 0 | $0 | $971,426 | $24,345 |
| Joseph C Dolan | EVP/CFO Officer | 0 | $0 | $358,890 | $38,564 |
| R Scott Warwick | Fmr Pres/CAO (through July 2023) Officer | 30 | $0 | $360,712 | $19,525 |
| Lucas D Johnson Sr | Fmr Pres/CAO; Fmr EVP-Phys Ent Former | 0 | $0 | $337,127 | $12,902 |
| Chester R Ramsey | Chief Medical Physicist Highest-paid employee | 5 | $245,461 | $0 | $44,057 |
| Benjamin J Devore | President & CAO Officer | 30 | $214,455 | $0 | $35,945 |
| Jessica N Hodge | Director of Oncology Pharmacy Svcs Highest-paid employee | 50 | $157,409 | $0 | $41,574 |
| Mitzi F Anderson | VP - Financial Services Officer | 7 | $145,611 | $0 | $27,391 |
| Carol S Micki | Director of Radiation Oncology Highest-paid employee | 50 | $128,210 | $0 | $30,083 |
| Nicholeah J Lewallen | Pharmacy Manager Highest-paid employee | 50 | $110,755 | $0 | $37,563 |
| Deborah K Bowles | Director of Cancer Support Svcs Highest-paid employee | 50 | $113,414 | $0 | $6,856 |
| King Purnell | Director/Chair Trustee or director, Officer | 0 | $0 | $1,630 | $0 |
| Cosby Stone | Director Trustee or director | 0 | $0 | $1,595 | $0 |
| Donald Hickman | Director Trustee or director | 0 | $0 | $1,498 | $0 |
| Joe Sutter | Director Trustee or director | 0 | $0 | $1,462 | $0 |
| William Seale | Director Trustee or director | 0 | $0 | $1,321 | $0 |
| Jorge Sanabria | Director Trustee or director | 0 | $0 | $1,234 | $0 |
| Janice McKinley | Director Trustee or director | 0 | $0 | $1,222 | $0 |
| Timothy Matthews | Director Trustee or director | 0 | $0 | $1,196 | $0 |
| James Tramontana MD | Director Trustee or director | 0 | $0 | $1,196 | $0 |
| Edgar Gray | Director Trustee or director | 0 | $0 | $1,054 | $0 |
| Dave Miller | Director Trustee or director | 0 | $0 | $1,044 | $0 |
| Alvin Nance | Director Trustee or director | 0 | $0 | $1,044 | $0 |
| Leslye Hartsell | Director Trustee or director | 0 | $0 | $1,027 | $0 |
| James Gibson | Director Trustee or director | 0 | $0 | $1,008 | $0 |
| Gerald Boyd | Director Trustee or director | 0 | $0 | $977 | $0 |
| Stephanie Flood | Director Trustee or director | 0 | $0 | $808 | $0 |
| Mitchell Dickson MD | Director Trustee or director | 0 | $0 | $796 | $0 |
| Willard Campbell MD | Director Trustee or director | 0 | $0 | $0 | $0 |
| Michael Casey MD | Director Trustee or director | 0 | $0 | $0 | $0 |
| Ronni Chandler | Fmr Director (through June 2023) Trustee or director | 0 | $0 | $0 | $0 |
| Bill Myers | Director Trustee or director | 0 | $0 | $0 | $0 |
| Linda Ogle | Director Trustee or director | 0 | $0 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 1420 CENTERPOINT BLVD BLDG C, KNOXVILLE, TN 37932-1960
- In care of
- % AMY DELONG TAX DEPARTMENT
- Principal officer (990 for 2024)
- James D VanderSteeg, 244 Ft Sanders W Blvd, Knoxville, TN 37922
- Signed the 990
- Joseph C Dolan, EVP/CFO
- Phone
- (865) 374-5329
- Website
- www.covenanthealth.com
Mission
Thompson Cancer Survival Center provides support services for cancer patients, in alignment with Covenant Health's mission to serve the community by improving the quality of life through better health, regardless of a patient's ability to pay.
Program accomplishments
- At Thompson Cancer Survival Center, leading cancer specialists use the most advanced technologies to achieve breakthrough successes in treating many types of cancer. Our network of cancer care providers, including those in Thompson Oncology Group (our own medical oncology, hematology, and gynecologic oncology practice), is supported by a team of patient navigators, oncology pharmacists, dietitians, genetics counselors, clinical trial specialists, physicists, therapists, technologists, oncology nurses, social workers, and counselors, all working to treat and beat cancer. In addition to innovative technologies and treatment methodologies, Covenant Health added a new proton therapy center to the treatment options at Thompson Cancer Survival Center. Patients can now receive proton therapy as part of Covenant Health's umbrella of cancer services offered at Thompson Cancer Survival Center locations throughout the region and the Covenant Cancer Network. One of only 45 proton therapy facilities in the United States, Thompson Proton Center offers an advanced form of radiation therapy that uses beams of high-energy protons to treat various forms of cancer, while protecting nearby healthy tissue and vital organs from unnecessary radiation. Thompson Proton Center treated 345 patients in 2024. SERVICEThompson Cancer Survival Center ("TCSC") offers a range of cancer support services with the aim of providing patients receiving cancer treatment the best possible outcome for their individual situations. Support services include cancer outreach services, treatment care coordination and oncology clinical trials.Covenant Health facilities identify and refer patients to the TCSC Social Services department. In 2024, there were 2,118 new patient referrals to Social Services and 6,254 follow-up patients. The Social Services department includes a nutritional counseling and education program and a genetics clinic. The nutritional counseling and education program had 2,763 new patient referrals in 2024 with 4,019 follow-up assessments and 3,254 education encounters to support patients. In 2024, the genetics clinic received referrals for 1,098 new patients who were in need of genetic counseling. Of these patients, 748 were scheduled, 522 completed genetic counseling, and 412 elected to pursue genetic testing. All patients were able to receive full personal and family history reviews, allowing for a thorough risk assessment for the potential of a hereditary cancer syndrome or other familial risk factors possibly not accounted for through genetic testing. The patients received education and counseling regarding their pursuit of genetic testing. When appropriate, patients received information about support resources for individuals in similar circumstances. Finally, all patients received recommendations for risk-reduction strategies personalized for their individual health history, family history, and genetic test results when available. A goal of TCSC is to provide treatment care coordination for each patient. This goal is achieved by two means: the Multidisciplinary Treatment program and the Nurse Navigator program.Multidisciplinary Treatment is a process of individual patient consultation with members of the patient's oncology care team, where treatment options are discussed based on that individual's circumstances. This approach gives the physician the opportunity to relate one-on-one with the oncology patient and explain treatment choices in layperson's language. Patients needing care coordination come from various Covenant Health organizations and other facilities. The program currently consists of 14 nurses, one department assistant and one conference and patient housing coordinator to support oncology patients throughout the Covenant health system.The TCSC Nurse Navigator program was developed to help oncology patients overcome multiple barriers to healthcare, depending on their needs. Common barriers include financial, education, transportation, language, emotional, and the complexities of navigating a health system. The TCSC Nurse Navigators guide patients to sources of financial support, help complete paperwork, educate patients on diagnoses and medical procedures, arrange and coordinate appointments with multiple providers, help with transportation, assist with housing, communicate with providers about unique patient needs, ensure medical records arrive at scheduled appointments, direct patients to support groups or counseling services, and attend patient appointments for support. Nurse Navigators work diligently to meet the needs of patients and families and become their liaisons between all physicians and services. There were 27,121 oncology patient education encounters in 2024, and 3,371 patients were assisted with their treatment by TCSC Nurse Navigators. For those patients who receive curative treatment, over 126 Survivorship Care Plans were completed by Nurse Navigators and discussed with patients in 2024.The Nurse Navigator is actively involved in the multidisciplinary care of patients. Nurse Navigators currently schedule, organize, oversee, summarize, and provide follow-up for 4-5 multidisciplinary cancer conferences per week. In 2024, 1,165 patients were presented at multidisciplinary conferences, with 140 of those patients being seen in our clinics where a Nurse Navigator is in attendance. TCSC continued all conferences in-person as well as via virtual format. In 2022, Fort Sanders Regional Medical Center became the first hospital in Tennessee to receive accreditation from National Accreditation Program for Rectal Cancer (NAPRC), affirming a commitment to providing the best possible care to patients with rectal cancer. Oncology clinical trials offer cancer patients access to proven standard cancer treatments and to newly developed cutting-edge therapies. Since the opening of TCSC in 1988, the Clinical Trials Department has enrolled 2,772 patients in oncology clinical trials. In 2024, the TCSC Clinical Trials department had 7 active-treatment patients and 94 patients in follow-up studies. Because of the excellent research reputation of Dr. David Chism and the research team, we continue to have new clinical trial opportunities offered to our team on a weekly basis. To help with screening efforts, Research Nurse Coordinators are assigned to specific physician schedules and to specific locations for coverage, including Thompson Oncology Groups in Oak Ridge, Sevierville, West Knoxville, Downtown Knoxville, and Lenoir City. Opening new studies increases referrals locally and regionally and gives current patients the ability to be treated with state-of-the-art care in their own communities. Involvement in prevention and treatment trials offers improved health strategies for individuals at risk for certain cancers.Other TCSC programs in place to support Covenant Health patients undergoing cancer treatment include the East Tennessee Cancer Registry and Cancer Outreach Services.Expenses $11,975,987 · grants $126,067 · revenue $4,287,147
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 62-1250943
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Hospital or medical research organization
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1986
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Assets (IRS master file)
- $57,041,728
- Income (IRS master file)
- $7,887,756
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $7,887,756 | $13,462,262 | $57,041,728 | XML |
| 990-T | December 2024 | – | – | – | IRS |
| 990 | December 2023 | $8,057,852 | $12,677,535 | $58,441,095 | XML |
| 990 | December 2022 | $28,323,238 | $10,066,123 | $59,886,115 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990 | December 2017 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 62-1250943).
Questions about THE THOMPSON CANCER SURVIVAL CENTER
- What is the EIN of THE THOMPSON CANCER SURVIVAL CENTER?
- The employer identification number (EIN) of THE THOMPSON CANCER SURVIVAL CENTER is 62-1250943.
- Is THE THOMPSON CANCER SURVIVAL CENTER tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1986.
- Are donations to THE THOMPSON CANCER SURVIVAL CENTER tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does THE THOMPSON CANCER SURVIVAL CENTER file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of THE THOMPSON CANCER SURVIVAL CENTER due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did THE THOMPSON CANCER SURVIVAL CENTER last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of THE THOMPSON CANCER SURVIVAL CENTER?
- The 990 for the year ended December 31, 2024 names James D VanderSteeg.
- Who are the officers and directors of THE THOMPSON CANCER SURVIVAL CENTER?
- The 990 for the year ended December 31, 2024 lists 29 people; 8 received compensation from the organization.
- How much revenue does THE THOMPSON CANCER SURVIVAL CENTER have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $7,887,756, expenses of $13,462,262 and total assets of $57,041,728 at year end.
Other nonprofits in KNOXVILLE
- UNIVERSITY HEALTH SYSTEM INC EIN 31-1626179 · last filed 990 for 2024
- PARKWEST MEDICAL CENTER EIN 58-1897274 · last filed 990 for 2024
- FORT SANDERS REGIONAL MEDICAL CENTER EIN 62-0528340 · last filed 990 for 2024
- EAST TENNESSEE CHILDRENS HOSPITAL ASSOCIATION INC EIN 62-6002604 · last filed 990 for 2025
- THE UNIVERSITY OF TENNESSEE FOUNDAT ION INC EIN 62-1844686 · last filed 990 for 2025
- KNOXVILLE TVA EMPLOYEES CREDIT UNIO EIN 62-0263105 · last filed 990 for 2025
- COVENANT HEALTH EIN 62-1646734 · last filed 990 for 2024
- METHODIST MEDICAL CENTER EIN 62-0636239 · last filed 990 for 2024